Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Observational Study of Pembrolizumab for Chinese Advanced NSCLC

NCT04153097 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.

NCT NCT04153097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Observational Study of Pembrolizumab for Chinese Advanced NSCLC
Lead sponsor
First Affiliated Hospital of Zhejiang University
Phase
Observational
Overall status
Unknown status
Start date
July 30, 2020
Completion date
December 31, 2024
Enrollment
500 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer